Bortezomib in multiple myeloma.
Cecchi
Michele
M
Caccese
Erminia
E
Messori
Andrea
A
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D001897:Boronic Acids / Q000191:economics* / Q000627:therapeutic use; D000069286:Bortezomib; D003362:Cost-Benefit Analysis; D003907:Dexamethasone / Q000191:economics* / Q000627:therapeutic use; D016527:Drug Costs; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D011719:Pyrazines / Q000191:economics* / Q000627:therapeutic use; D012008:Recurrence; D015996:Survival Rate
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone